idiopathic pulmonary fibrosis (IPF)

July 17, 2017

Trial Launches to Evaluate Ofev on IPF-Predicting Biomarkers

Boehringer Ingelheim Pharmaceuticals announced the launch of a new clinical trial to investigate the effects of Ofev (nintedanib) on certain blood biomarkers that might help identify fibrosis and loss of lung function ... Read more

April 8, 2016April 8, 2016

Search for COPD, IPF and Asthma Treatments Could Benefit from Immune System Suppression Research

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

A collaborative study led by Weill Cornell Medicine investigators suggests that starving the immune system might lead to treatments for lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), ... Read more

March 28, 2016April 4, 2016

Drug Company Collaboration for IPF Therapy Leads to Positive Results; Phase 1 Trial to Launch in 2017

Idiopathic Pulmonary Fibrosis, News

Synairgen recently announced positive results from its collaboration with Pharmaxis in their goal to develop a lysyl oxidase type 2 enzyme (LOXL2) inhibitor as an innovative treatment for the life-threatening lung disease ... Read more

March 11, 2016May 13, 2016

For Idiopathic Pulmonary Fibrosis, NuQ Blood Test a Promising Diagnostic Tool

Idiopathic Pulmonary Fibrosis, News

VolitionRx, dedicated to the development of blood-based diagnostic tests, recently announced preliminary data from a pilot study showing that its blood test NuQ successfully detected 86 percent of patients with ... Read more

February 29, 2016May 13, 2016

Ofev (Nintedanib) Slows IPF Disease Progression, According to Analysis of Studies

Idiopathic Pulmonary Fibrosis, News

An analysis of the Phase II TOMORROW trial and two Phase III INPULSIS trials (INPULSIS-1 and INPULSIS-2), analyzing the safety and efficacy outcomes for Ofev (nintedanib, developed by Boehringer Ingelheim), revealed that ... Read more

February 25, 2016March 16, 2016

‘Breathless’ Campaign, to Raise Awareness of IPF, Launched by Musician Joe Nichols and Boehringer Ingelheim

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals and country music artist Joe Nichols are launching a national education campaign called Breathless aimed at raising awareness for idiopathic pulmonary fibrosis (IPF), its symptoms, and the importance of ... Read more

January 11, 2016January 11, 2016

Pulmonary Fibrosis Foundation Care Center Network adds UT Medicine San Antonio

News

UT Medicine San Antonio, the academic clinical practice of the School of Medicine at the University of Texas Health Science Center at San Antonio, recently announced it has joined the ... Read more

October 12, 2015November 5, 2015

MediciNova’s MN-001 (Tipelukast) IPF Therapy Progresses to Phase 2 Clinical Trial

Idiopathic Pulmonary Fibrosis, News

MediciNova, Inc. announced the progression of MN-001 (tipelukast), a small molecule drug to treat idiopathic pulmonary fibrosis (IPF), into phase II clinical trials. This development follows the culmination of the ... Read more

July 16, 2015July 16, 2015

THERAMetrics Issued New Patent For Idiopathic Pulmonary Fibrosis Treatment

News

THERAMetrics holding AG recently announced that it has been granted a patent for a pharmaceutical kit that includes targeted treatment of Idiopathic Pulmonary Fibrosis (IPF). The patent was granted by the European ... Read more